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Fragile X syndrome is caused by loss of expression
of FMRP, a protein proposed to act as a regulator of
mRNA translation which promotes synaptic matura-
tion and function. Now FMRP has been found to
associate with the RNP complex that mediates post-
transcriptional silencing by RNAi.
Fragile X syndrome is one of the most common forms
of inherited mental retardation. In most cases, the
disease is caused by the methylation-induced trans-
criptional silencing of the FMR1 gene which occurs as
a result of the expansion of a CGG repeat in the
gene’s 5′ untranslated region (reviewed in [1]). This
leads to the loss of production of gene product FMRP,
an RNA-binding protein that contains several
structural motifs implicated in RNA interactions — two
KH domains and one RGG motif. FMRP associates
with translating polyribosomes as part of a large
ribonucleoprotein (RNP) complex [2], suggesting a
role in regulating translation. Indeed, hundreds of
mRNA transcripts exhibit abnormal polyribosome
profiles in cells derived from patients with fragile X
syndrome [3], and biochemical studies of FMRP
suggest that it inhibits translation [1].
Pathological studies of the brains from fragile X
syndrome patients and Fmr1 knockout mice have
revealed abnormal dendritic spines on neurons,
implicating FMRP in synapse formation and function
[4]. Both in vitro and in vivo neuronal studies have
shown that FMRP is located at the synapse, and the
loss of FMRP alters synaptic plasticity [1], which is
thought to underlie learning and memory. Interest-
ingly, there is increasing evidence that synaptic effi-
cacy is controlled in part by the regulated translation
of mRNAs stored in dendrites [5]. It is tempting to
speculate on a potential link between FMRP-mediated
translation control and synapse function, more so
since FMRP is associated with ribosomes localized to
postsynaptic dendritic spines [6].
Ishizuka et al. [7] purified the Drosophila homolog 
of FMRP (dFMR1) as a complex from cell lysates to
find what proteins stably associate with it. They used
dFMR1 in the hope of applying genetic analysis to
associated proteins, a fortunate choice. Drosophila has
a single FMR1 homolog, and the dFMR1 gene product
has similar biochemical properties to mammalian
FMRP [8]. Moreover, mutation studies indicated that
dFMR1 regulates synapse growth and function in the
fly [9,10]. Ishizuka et al. [7] purified from Drosophila cell
lysates a dFMR1 complex that contained two ribosomal
proteins, L5 and L11, 5S rRNA and, surprisingly, AGO2,
a protein implicated in RNA interference (RNAi).
RNAi is a conserved gene-silencing response to
double-stranded RNA (dsRNA), which mediates resis-
tance to both endogenous and exogenous parasitic
nucleic acids, encoded by transposons and viruses,
respectively (reviewed in [11]). RNAi also regulates the
expression of cellular protein-coding genes. A signa-
ture feature of RNAi is the formation of small RNAs,
21–23 nucleotides in length, which are generated by a
class of conserved RNase III enzymes called the
DICER family (Figure 1). 
DICER recognizes and cleaves dsRNA molecules to
produce 21–23 nucleotide fragments [12]. It has been
shown that these fragments, called short interfering
RNAs (siRNAs), can substitute for dsRNA in stimu-
lating degradation of homologous mRNAs, the primary
mechanism of gene silencing in RNAi [13]. Thus,
siRNAs are thought to be the direct guides that iden-
tify homologous mRNA substrates for degradation.
DICER also processes short hairpin RNAs transcribed
from endogenous genes [11], producing 21 nucleotide
single-stranded micro-RNAs (miRNAs). In contrast to
the siRNA pathway, miRNAs can silence gene expres-
sion by repressing translation of complementary
mRNA transcripts [14,15]. There are estimated to be
possibly hundreds of miRNA-encoding genes in the
genome [16].
Biochemical analysis using Drosophila extracts has
revealed how siRNAs interact with mRNA substrates
(Figure 1A). It was observed that siRNAs associate into
a nuclease complex dubbed RISC which rec-ognizes
and cleaves homologous mRNAs [17]. The cleavage
reaction is endonucleolytic and occurs at a central site
in the region homologous to the siRNA [13]. One of the
subunits of RISC is AGO2 [18], the same protein found
by Ishizuka et al. [7] to associate with dFMR1. At the
same time, Caudy et al. [19] were identifying proteins
associated with RISC activity from partially purified
Drosophila preparations, and found that dFMR1 is one
such associated factor. Together, these initial observa-
tions suggested that dFMR1 may be involved in RNAi.
The two groups [7,19] report a variety of exper-
imental evidence in support of this idea. dFMR1 co-
immunoprecipitates with AGO2 and another RISC
protein (VIG) from Drosophila cell lysates. Moreover,
both a miRNA (miR-2b) and siRNAs can co-immuno-
precipitate with dFMR1, consistent with the view that
dFMR1 associates with RISC. The most compelling
biochemical evidence, provided by Caudy et al. [19],
is that immunoprecipitates of dFMR1 from dsRNA-
challenged cells have RISC activity. 
All this suggests that dFMR1 is intimately asso-
ciated with RISC in Drosophila cells; but is it required
for mRNA degradation? The matter is unclear. Both
groups [7,19] performed a similar experiment to deter-
mine the function of dFMR1. They used RNAi to
silence the endogenous dFMR1 gene in cells, and
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then challenged these cells with a heterologous
dsRNA complementary to a reporter gene as a way of
measuring RNAi activity in the absence of dFMR1. An
earlier application of this approach established a role
for AGO2 in mRNA degradation by RNAi [18], sug-
gesting it can detect strong functional interactions.
However, Caudy et al. [19] detected only a weak
requirement for dFMR1, and Ishizuka et al. [7] detected
none. But each group measured RNAi activity semi-
quantitatively by reporter-protein levels. Direct analy-
sis of reporter mRNA levels might have revealed sim-
ilarities or differences that were not detected at the
protein level. Clearly more work is needed to resolve
this issue.
What is clear is that dFMR1 is not an essential
factor for RNAi-mediated degradation. Rather than
being a constitutive component of transcript-cleaving
RISC, dFMR1 might be an accessory factor that asso-
ciates with RISC but uses another mechanism to reg-
ulate its targets. This interpretation fits nicely with the
other mechanism being translational repression, 
as dFMR1 and FMRP have been shown to repress
translation of select mRNAs, as do some miRNAs
[3,9,14,15,20]. Because miRNAs and dFMR1 interact
with each other as well as with RISC, it is quite possi-
ble that dFMR1 is targeted to substrate transcripts as
part of a RISC complex that is guided by miRNAs.
Thus, a RISC core might interact with different combi-
nations of RNA and protein accessory factors to carry
out either transcript cleavage or translation control.
An alternative scenario is that dFMR1-associated
RISC complexes may only use a subset of trigger
siRNAs or miRNAs available. dFMR1 itself may con-
tribute to such RNA specificity, as FMRP was found to
selectively bind RNA oligonucleotides with G-quartet
structures adjacent to short RNA helices [3,20]. While
it was originally proposed that FMRP directly binds to
mRNA substrates with these structural features,
FMRP may instead recognize specific miRNAs with
these features, which then guide FMRP to its correct
targets. It is possible that some, but not all, siRNAs
associate with FMRP and guide RISC complexes that
are competent to degrade mRNA as well.
The connection between the RNAi and fragile X fields
is likely to grow as we find out which small RNAs
mediate translational repression by dFMR1 and FMRP,
and how the repressive mechanism operates. Never-
theless, it is worth pondering that fragile X syndrome
may be the result of a defect in the RNAi activity within
neurons, making its molecular nature a RISCy business.
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Figure 1. A model for dFMR1’s role in RNAi.
(A) The mRNA cleavage/degradation
pathway is initiated by dsRNA conversion
to siRNAs, which associate with RISC
complexes. The proteins AGO2, VIG and
dFMR1 also associate with RISC. dFMR1,
and possibly VIG, are not found in all
RISC complexes, as they appear not to be
absolutely essential for the degradation
reaction. These assembled complexes are
competent to carry out target mRNA
recognition and cleavage from immuno-
precipitates, though it is unclear whether
the complexes remain assembled during
the cleavage reaction. (B) The translation
repression pathway is initiated by miRNA
precursor processing to mature miRNAs,
which associate with related RISC com-
plexes. AGO2, VIG, and dFMR1 are also
associated with these complexes. The
relationship between assembled miRNA
complexes and mRNA translation control
is surmised by a variety of circumstantial
evidence implicating some complex com-
ponents — miRNAs and dFMR1 — in
translation control.
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